Contrast enhanced computed tomography and 18-fluorine-labelled 2-deoxy-2-fluoro-d-glucose positron emission tomography/computed tomography correlation in the management of a patient with primary mediastinal seminoma and candidate to liver transplant

Gazzetta Medica Italiana Archivio per le Scienze Mediche

Volumn 170, Issue 6, 2011, Pages 449-455

  Niccoli Asabella, A ^a   Altini, C ^a   Notaristefano, A ^a   Iuele, F ^a   Rubini, G ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Disease management; Seminoma; Tomography, X ray computed

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CAVA VEIN DISEASE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONGENITAL LIVER SHUNT; CONTRAST ENHANCEMENT; DRUG UPTAKE; DYSPNEA; GOITER; HEART RIGHT VENTRICLE FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIVER BIOPSY; LIVER DISEASE; MALE; MEDIASTINUM TUMOR; MEDICAL HISTORY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PREDICTIVE VALUE; PRIMARY MEDIASTINAL SEMINOMA; SEMINOMA; THORACOTOMY; VEIN THROMBOSIS; VITAMIN DEFICIENCY;

EID: 84856576888     PISSN: 03933660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Moran CA, Suster S, Prygodzki RM, Koss MN. Primary germ cell tumors of the mediastinum: mediastinal seminomas-a clinicopathologic and immunohistochemical study of 120 cases. Cancer 1997;80:691-8. (Pubitemid 27339824)
2. Nakamura H, Hashimoto T, Kusama H et al. Primary seminoma in the middle mediastinum. Internal Medicine 2004;43:1191-3. (Pubitemid 40074159)
3. Priola SM, Priola AM, Cardinale L et al. The anterior mediastinum: anatomy and imaging procedures. Radiol Med 2006;111:295-311.
4. Rosada-de-Christenson ML, Templeton PA, Moran CA. Mediastinal germ cell tumors: Radiologic and pathologic correlation. RadioGraphics 1992;12:1013-30.
5. Ravenel JG, Gordon LL, Block MI, Chaudlhary U. Primary posterior mediastinal seminoma. AJR 2004;183:1835-7. (Pubitemid 44210567)
6. Bokemeyer C, Droz JP, Horwich A et al. Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome. Cancer 2001;91:1394-401. (Pubitemid 32267053)
7. Schmoll HJ, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004;15:1179-200.
8. De Giorgi U, Pupi A, Fiorentini G, et al. FDG-PET in the management of germ cell tumor. Annals of Oncology 2005;(Supplement 4):iv90-iv94. (Pubitemid 43084953)
9. Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Partridge SE, Huddart RA. Fluorodeoxyglucose PET in the initial staging of germ cell tumors. Eur J Nucl Med 2000;27:590-4. (Pubitemid 30262626)
10. Bokemeyer C, Kollmannsberger C. Oechsle K et al. Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG-PET. Br J Cancer 2002;86:506-11. (Pubitemid 34185083)
11. De Santis M, Becherer A, Bokemeyer C et al. 2-18fluoro-deoxy-D-Glucose Positron Emission Tomography is a reliable predictor for viable tumor in postchemoterapy seminoma: an update of the prospective multicentric SEMPET trial. J Clin Oncol 2004;22:1034-9. (Pubitemid 41095035)
12. Feltrin GP, Zandonà M, Borile V et al. Fondamenti sui mezzi di contrasto iodati e reazioni averse. Radiol Med 2004;Suppl I al N.4;8-31.